Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Dla Piper Llp (ILMN) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Dla Piper Llp (ILMN) lobbying for?
Summary of the lobbying data:
– Illumina Inc. hired multiple lobbying firms, including Dla Piper Llp (Us), Mercury Public Affairs, and Avenue Solutions, Inc., among others, for their lobbying efforts.
– The general issues they lobbied on were Health Issues, Trade (domestic/foreign), and Government Issues.
– The specific issues they lobbied on included promoting competition and accelerating non-discriminatory public access to its lifesaving multi-cancer early detection test, federal antitrust policy and implementation, legislation and regulations affecting sequencing and array-based solutions for genetic research, clinical and applied markets, and discussions related to genomics.
– The government agencies they lobbied were Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), House of Representatives, Department of Health & Human Services (HHS), Senate, U.S. Trade Representative (USTR), Natl Security Council (NSC), Executive Office of the President (EOP), Department of Commerce (DOC).
One could infer that Illumina is lobbying on these issues in order to influence government policies and regulations that could impact their ability to innovate and grow their business in the field of genomics and related healthcare technologies. They appear to be seeking support for their efforts to promote competition and accelerate non-discriminatory public access to their cancer detection test, as well as seeking funding for scientific research and development. Additionally, they may be seeking to protect their business interests by advocating for federal antitrust policies and regulations that are favorable to their industry.
